S.Biomedics Co., Ltd.
304360 | KO
Overview
Corporate Details
- ISIN(s):
- KR7304360001
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 성동구 성수이로26길 28 (성수동2가, 우일벤처타운) 4층, 성동구
- Website:
- https://www.sbiomedics.com/eng/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.3 MB | ||
| 2025-07-11 00:00 |
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
|
Korean | 107.2 KB | ||
| 2025-06-18 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 104.1 KB | ||
| 2025-06-16 00:00 |
Share Issue/Capital Change
전환가액의조정 (제6회차)
|
Korean | 10.9 KB | ||
| 2025-06-16 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2025-06-13 00:00 |
Share Issue/Capital Change
전환가액의조정 (제5회차)
|
Korean | 10.9 KB | ||
| 2025-06-04 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 107.6 KB | ||
| 2025-05-14 00:00 |
Regulatory Filings
신규시설투자등
|
Korean | 7.5 KB | ||
| 2025-05-14 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.2 MB | ||
| 2025-04-30 00:00 |
Regulatory Filings
소속부변경
|
Korean | 3.6 KB | ||
| 2025-04-01 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 113.8 KB | ||
| 2025-03-28 00:00 |
AGM Information
정기주주총회결과
|
Korean | 28.3 KB | ||
| 2025-03-28 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 10.3 KB | ||
| 2025-03-28 00:00 |
Board/Management Information
[기재정정]사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 13.3 KB | ||
| 2025-03-25 00:00 |
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
|
Korean | 160.7 KB |
Automate Your Workflow. Get a real-time feed of all S.Biomedics Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for S.Biomedics Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for S.Biomedics Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Provides NGS-based diagnostics, software, and liquid biopsy for precision oncology and healthcare.
South Korea
354200
South Korea
354200
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France
COX
France
COX
Developing therapies for rare CNS disorders, specializing in narcolepsy and sleep-wake issues.
United States of America
NLSP
United States of America
NLSP
Develops a non-invasive electric field therapy to disrupt and treat aggressive solid tumor cancers.
United States of America
NVCR
United States of America
NVCR
Repurposing drugs for fibrosis and oncology using proprietary cocrystal technology.
United Kingdom
NFX
United Kingdom
NFX
Developing protein degradation medicines to treat cancer and autoimmune diseases.
United States of America
NRIX
United States of America
NRIX
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea
244460
South Korea
244460
United States of America
OABIW
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom
ONC
United Kingdom
ONC
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea
382150
South Korea
382150